Results 11 to 20 of about 5,648 (180)
Peripheral T-Cell Lymphomas in Southern Taiwan: Epidemiology, Treatment Patterns, and Long-Term Outcomes. [PDF]
EJHaemABSTRACT Peripheral T‐cell lymphomas (PTCLs) are heterogeneous neoplasms with poor prognosis and marked geographic variation. Data from Taiwan remain limited. We conducted a 15‐year retrospective cohort study of 249 patients diagnosed with PTCL at two major centers in southern Taiwan between 2010 and 2024 to characterize regional epidemiology, real ...
Huang BY +9 more
europepmc +2 more sources
Brentuximab vedotin in the treatment of CD30+ PTCL [PDF]
Blood, 2019 In this timely Blood Spotlight, Barta et al summarize for the practicing hematologist the strengths and limitations of current data on brentuximab vedotin–based treatment in peripheral T-cell lymphoma (PTCL).
Stefan K. Barta +2 more
openaire +2 more sources
Efficient Resource Management for Sum Capacity Maximization in 5G NOMA Systems
Applied System Innovation, 2019 The modern cellular technologies are expected to provide high data rates and massive connectivity in fifth generation (5G) systems; however, this may be impossible through traditional radio access techniques.
Azhar Ali +5 more
doaj +1 more source
Frontiers in Immunology, 2023 AimsThe differential diagnosis between ALK-negative anaplastic large cell lymphoma (ALK- ALCL) and peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS) with high expression of CD30 (CD30high) are essential.
Chenxi Xiang +19 more
doaj +1 more source
Genomics of Peripheral T-Cell Lymphoma and Its Implications for Personalized Medicine
Frontiers in Oncology, 2020 Peripheral T-cell lymphoma (PTCL) is a rare, heterogenous group of mature T-cell neoplasms that comprise 10–15% of non-Hodgkin lymphoma cases in the United States. All subtypes of PTCL, except for ALK+ anaplastic T-cell lymphoma, are associated with poor
Yumeng Zhang +4 more
doaj +1 more source
Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigens. [PDF]
PLoS ONE, 2011 Peripheral T-cell lymphomas (PTCL) are generally less common and pursue a more aggressive clinical course than B-cell lymphomas, with the T-cell phenotype itself being a poor prognostic factor in adult non-Hodgkin lymphoma (NHL).
Christopher D O Cooper +6 more
doaj +1 more source
Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking
eLife, 2021 Background: Although advance has been made in understanding the pathogenesis of mature T-cell neoplasms, the initiation and progression of angioimmunoblastic T-cell lymphoma (AITL) and peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS ...
Shuhua Cheng +3 more
doaj +1 more source
Pulmonary T-cell lymphoma masquerading as eosinophilic pneumonitis
Lung India, 2019 Primary pulmonary T-cell lymphoma is an unusual subtype of peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS). This is a general term used to describe a diverse group of T-cell-type lymphomas that would otherwise not be classified as a PTCL ...
Najam Siddiqui +5 more
doaj +1 more source
Diagnostic Utility of SOX4 Expression in Adult T-Cell Leukemia/Lymphoma
Diagnostics, 2021 Differentiation between adult T-cell leukemia/lymphoma (ATLL) and peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), is often challenging based on pathological findings alone.
Atsuko Nasu +8 more
doaj +1 more source
THE ROLE OF RADIATION THERAPY IN THE TREATMENT OF PTCL-NOS
Проблеми радіаційної медицини та радіобіології = Problems of Radiation Medicine and Radiobiology, 2023 Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of lymphoproliferative disorders, accounting for about 10 % of all non-Hodgkin lymphomas. The most common subtype is peripheral T-cell lymphoma, unclassified (PTCL-NOS), accounting for about 26 % of all PTCLs.
I, Kriachok +4 more
openaire +2 more sources